PT  - JOURNAL ARTICLE
AU  - Huang, Jiayi
AU  - Alzahrani, Khaloud O.
AU  - Zhou, Ge
AU  - Alsalman, Shahad A.
AU  - Almansour, Ayidh M.
AU  - Alhadlaq, Meshari A.
AU  - Alhussain, Shaykhah
AU  - Alajlan, Abdullah A.
AU  - Al-Akeel, Saleh I.
AU  - Al Rashidy, Malfi S.
AU  - Alzauhair, Abdulrahman
AU  - AlReshoodi, Fahad M.
AU  - Alsufyani, Amani T.
AU  - Alotaibi, Nourah M.
AU  - Althubaiti, Afnan
AU  - Alshdokhi, Elaf
AU  - Alhamed, Ashwaq
AU  - Almusa, Manal
AU  - Almadi, Talah
AU  - Almutairi, Nouf
AU  - Mukhtar, Lenah E.
AU  - AlHarbi, Abdulmohsen L.
AU  - Banzhaf, Manuel
AU  - Milner, Mathew
AU  - AlArawi, Mohammad
AU  - Alajel, Sulaiman
AU  - Moradigaravand, Danesh
TI  - Large-scale Genomic Survey of Non-typhoidal <em>Salmonella enterica</em> serovar Minnesota Strains in Chicken Products Reveals the Emergence of Multidrug Resistant Clones
AID  - 10.1101/2024.07.28.24311129
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.28.24311129
4099  - http://medrxiv.org/content/early/2024/07/29/2024.07.28.24311129.short
4100  - http://medrxiv.org/content/early/2024/07/29/2024.07.28.24311129.full
AB  - Background Salmonella enterica serovar Minnesota (S. Minnesota) is an emerging serovar of non-typhoidal Salmonella, known to persist in the food chain and distribution systems, potentially leading to outbreaks of Salmonella infections in human settings. Understanding the population genomics and dynamics of this pathogen is key to designing preventative measures and containing its spread within the poultry production chain.Methods In this study, we conducted a large-scale study on S. Minnesota outbreak by fully characterizing population diversity and dynamics of a systematic collection from the poultry production chain in the Kingdom of Saudi Arabia (KSA). We sequenced 260 S. Minnesota strains from the western, eastern, and central regions of the country. We analyzed sequencing data to decipher the population diversity and dynamics of multidrug resistant strains and characterize the genetic basis of resistance and virulence. A hybrid long- and short-read sequencing approach was employed to analyze the population diversity of plasmids carrying antimicrobial resistance and virulence factors.Results Our results indicate the rise of four clones (Bayesian Analysis of Population Structure; BAPS groups) in Saudi Arabia, three of which were mixed with global strains. The clones emerged over the past five to ten years and exhibited circulation between countries. The transmission analysis shows evidence of the spread of strains across cities, between countries, and mixing of strains from different suppliers, on epidemiological time scales. The emerging clones also harbored a higher resistance and virulence level than ancestral clones, owing to the acquisition of multiple plasmids, most importantly the IncC plasmid. The IncC plasmid was a mosaic plasmid, which carried antimicrobial resistance islands with blaCMY-2, ESBL blaCTX-M, aminoglycoside, and tetracycline resistance genes, as well as a hyperpathogenicity island with yersiniabactin genes. The plasmidome analysis revealed a high level of dynamics in the IncC plasmid structures with various configurations of resistance genes.Conclusion Taken together, our results demonstrate a dynamic population and the emergence of multidrug-resistant clones in S. Minnesota. The results also highlight the role of plasmid acquisition and genomic variations in driving the concurrent evolution of pathogenicity and resistance in S. Minnesota.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by the baseline funding of BAS111080101 from King Abdullah University of Science and Technology (KAUST).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board (IRB) of the General Administration of Research and Studies, Ministry of Health, Saudi Arabia (No. 23-23 M), and the Institutional Biosafety and Bioethics Committee (IBEC) of King Abdullah University of Science and Technology (No. 22IBEC046).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe short- and long-read sequencing data were submitted to the European Nucleotide Archive (ENA) under study number PRJEB67737. Metadata, profiles of antimicrobial resistance genes/mutations, virulence factor genes, and plasmid replicons are provided in Supplemental Table S1. All other intermediate files and relevant tables, e.g. clustering information of plasmids and plasmid sequences, are available on the GitHub directory for the project: https://github.com/hjy1805/Sminnesota_project.  https://www.ebi.ac.uk/ena/browser/view/PRJEB67737